Close Menu

NEW YORK (360Dx) – Sekisui Diagnostics said today that the US Food and Drug Administration has cleared the company's Sekure HbA1c assay as an aid in the diagnosis of diabetes mellitus.

It also has been cleared to aid in identifying patients at risk of developing diabetes mellitus and for the monitoring of long-term blood glucose control of patients with the condition.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.